18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Nuclear Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002590000404PMID 11202454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging of a Metastatic Gastrointestinal Carcinoid by F-18-DOPA Positron Emission Tomography

  1999cited by this paper
• Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

  1999cited by this paper
• Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid.

  1999cited by this paper
• Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin.

  1999cited by this paper
• Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.

  1998cited by this paper
• Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma

  1998cited by this paper
• Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin

  1998cited by this paper
• Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.

  1998cited by this paper
• Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma.

  1997cited by this paper
• Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours

  1997cited by this paper
• Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.

  1997cited by this paper
• Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.

  1996cited by this paper
• In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine.

  1996cited by this paper
• Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.

  1996cited by this paper
• PET Imaging of Recurrent Medullary Thyroid Cancer

  1996cited by this paper
• Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.

  1996cited by this paper
• Pancreatic neuroendocrine tumors: diagnosis with PET.

  1995cited by this paper
• Simple rapid hydrolysis of acetyl protecting groups in the FDG synthesis using cation exchange resins.

  1995cited by this paper
• Accelerated image reconstruction using ordered subsets of projection data

  1994cited by this paper
• Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer.

  1994cited by this paper
• Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours

  1994cited by this paper
• FDG-PET for predicting the prognosis of malignant lymphoma

  1994cited by this paper
• Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

  1994cited by this paper
• Cancer Imaging Manual

  1993cited by this paper
• Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.

  1992cited by this paper
• Medullary carcinoma of the thyroid: current diagnosis and management.

  1991cited by this paper
• Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.

  1991cited by this paper
• Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies

  1991cited by this paper
• Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.

  1990cited by this paper
• Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET.

  1990cited by this paper
• Nigrostriatal function in humans studied with positron emission tomography

  1989cited by this paper
• Medullary Carcinoma of the Thyroid: A STUDY OF THE CLINICAL FEATURES AND PROGNOSTIC FACTORS IN 161 PATIENTS

  1984cited by this paper
• Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow‐up of medullary thyroid carcinoma

  1984cited by this paper
• Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.

  1974cited by this paper
• THE CYTOCHEMISTRY AND ULTRASTRUCTURE OF POLYPEPTIDE HORMONE-PRODUCING CELLS OF THE APUD SERIES AND THE EMBRYOLOGIC, PHYSIOLOGIC AND PATHOLOGIC IMPLICATIONS OF THE CONCEPT

  1969cited by this paper

• Diagnostica medico nucleare del carcinoma midollare tiroideo

  2025cites this paper
• Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients.

  2025cites this paper
• A Brief Summary of PET Imaging of Dopaminergic System

  2025cites this paper
• Medullary Thyroid Carcinoma: Imaging.

  2025cites this paper
• Diagnostic capabilities of PET/CT with 18F-DOPA in biochemical recurrence of medullary thyroid carcinoma: a retrospective study

  2024cites this paper
• PET imaging of dopaminergic system and clinical applications

  2024cites this paper
• Médecine nucléaire et cancers de la thyroïde en 2024 : iode 131, TEP et nouvelles approches théranostiques

  2024cites this paper
• Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review

  2023cites this paper
• Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities

  2023cites this paper
• The Role of 18F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels

  2023cites this paper
• Adrenal Functional Imaging.

  2022cites this paper
• Functional imaging in thyroid cancer patients with metastases and therapeutic implications.

  2022cites this paper
• Prospective study on the clinical relevance of 18F-DOPA positron emission tomography/computed tomography in patients with medullary thyroid carcinoma

  2022cites this paper
• Calcitonin-Negative Neuroendocrine Carcinoma of the Thyroid Gland: Case Report and Literature Review

  2021cites this paper
• Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives

  2021cites this paper
• Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT

  2021cites this paper
• Role of Non-FDG-PET/CT in Head and Neck Cancer.

  2021cites this paper
• PET in medullary thyroid carcinoma

  2021cites this paper
• Nucleophilic Synthesis of 6-l-[18F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?

  2020cites this paper
• Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition Study.

  2020cites this paper
• 18F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of Cancer.

  2020cites this paper
• Glucagon-Like Peptide-1 Receptor Imaging with [Lys 40 ( Ahx-HYNIC- 99m Tc / EDDA ) NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report

  2020cites this paper
• Comparison of 5 Different PET Radiopharmaceuticals for the Detection of Recurrent Medullary Thyroid Carcinoma

  2020cites this paper
• Non-FDG PET/CT.

  2020cites this paper
• Nuclear Medicine Imaging Techniques of the Neuroendocrine System

  2020cites this paper
• Molecular Imaging in Oncology

  2020influential citation
• Novel PET tracers: added value for endocrine disorders

  2019cites this paper
• Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma

  2019cites this paper
• Non-FDG Radiopharmaceuticals in Head and Neck PET Imaging: Current Techniques and Future Directions.

  2019cites this paper
• Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer

  2018cites this paper
• Chapter 5 PET Imaging in thyroid carcinoma

  2018cites this paper
• [18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• Metabolic PET/CT Imaging in Thyroid Cancer

  2018cites this paper
• The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values

  2017cites this paper
• Nuclear Oncology

  2017cites this paper
• Diagnostic Applications of Nuclear Medicine: Thyroid Tumors

  2017cites this paper
• University of Groningen Medullary Thyroid Carcinoma

  2017cites this paper
• Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff

  2017cites this paper
• Fluorine-18 labeled amino acids for tumor PET/CT imaging

  2017cites this paper
• 68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging

  2017cites this paper
• Radionuclide Therapy of Thyroid Tumors

  2016cites this paper
• 18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma

  2016cites this paper
• PET/CT in Medullary Thyroid Cancer

  2016cites this paper
• Clinical challenges with calcitonin-negative medullary thyroid carcinoma

  2016cites this paper
• The Physiology of Serum Calcitonin and Carcinoembryonic Antigen in Medullary Thyroid Cancer

  2016cites this paper
• Latomographieparémissionde positons et sesapplicationscliniques

  2016cites this paper
• Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy

  2016cites this paper
• Glucagon-Like Peptide-1 Receptor Imaging with [ Lys 40 ( Ahx-HYNIC-99 mTc / EDDA ) NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer : A Preliminary Report

  2015cites this paper
• Somatostatin Receptor Scintigraphy in Medullary Thyroid Cancer

  2015cites this paper
• Long-Term Follow-up in Medullary Thyroid Carcinoma.

  2015cites this paper
• Medullary Thyroid Carcinoma

  2015cites this paper
• Medullary Thyroid Carcinoma: Imaging.

  2015cites this paper
• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

  2015cites this paper
• Liver Metastases in Thyroid Cancer

  2015cites this paper
• American Thyroid Association guidelines for the management of medullary thyroid carcinoma

  2015cites this paper
• Update on medullary thyroid cancer.

  2014cites this paper
• 18F-Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of 18F-FDOPA

  2014cites this paper
• Functional Oncological Imaging of the Endocrine System

  2014cites this paper
• MEDÜLLER TİROİD KARSİNOMALI HASTALARIN TAKİBİNDE FDG PET FDG PET in the Follow-up of Medullary Thyroid Carcinoma Patients

  2014cites this paper
• Cabozantinib for progressive metastatic medullary thyroid cancer: a review

  2014cites this paper
• Cabozantinib for progressive metastatic medullary thyroid cancer: a review

  2014cites this paper
• Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.

  2014cites this paper
• Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography

  2014cites this paper
• Synthesis and biological evaluation of novel 99mTc-oxo and 99mTc-nitrido complexes with phenylalanine dithiocarbamate for tumor imaging

  2014cites this paper
• Cabozantinib for progressive metastatic medullary thyroid cancer: a review

  2014cites this paper
• Cabozantinib for progressive metastatic medullary thyroid cancer: a review

  2014cites this paper
• Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions

  2014cites this paper
• Role of 18F‐FDOPA PET/CT imaging in endocrinology

  2014cites this paper
• Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.

  2014cites this paper
• MEDÜLLER TİROİD KARSİNOMALI HASTALARIN TAKİBİNDE FDG PET

  2014cites this paper
• Department of Diagnostic Radiology

  2013cites this paper
• What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?

  2013cites this paper
• Glucagon-Like Peptide-1 Receptor Imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report

  2013cites this paper
• Depicting Medullary Thyroid Cancer Recurrence: The Past and the Future of Nuclear Medicine Imaging

  2013cites this paper
• Recurrent Medullary Carcinoma detected by Gallium-68 Positron Emission Tomography

  2013cites this paper
• Molecular imaging in oncology.

  2013cites this paper
• PET/CT imaging in neuroblastoma.

  2013cites this paper
• Synthesis of functionalized aryl fluorides using organolithium reagents in flow microreactors.

  2013cites this paper
• 18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type

  2013influential citation
• Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis

  2013cites this paper
• Thyroid and Parathyroid Tumors

  2013cites this paper
• Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer.

  2013cites this paper
• On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass

  2013cites this paper
• Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.

  2013cites this paper
• 18F‐FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma

  2012cites this paper
• Contemporary nuclear medicine imaging of neuroendocrine tumours.

  2012cites this paper
• Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer

  2012cites this paper
• PET Imaging in Recurrent Medullary Thyroid Carcinoma

  2012cites this paper
• Clinical Relevance of 18 F-FDG PET and 18 F-DOPA PET in Recurrent Medullary Thyroid Carcinoma

  2012cites this paper
• Correlation between Calcitonin Levels and [18F]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer

  2012cites this paper
• Radioactive Iodine Therapy

  2012cites this paper
• Medullary Thyroid Cancer

  2012cites this paper
• Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis

  2012cites this paper
• 18F-DOPA PET/CT in Neuroblastoma: Comparison of Conventional Imaging With CT/MR

  2012cites this paper
• Amino Acid transporter-targeted radiotracers for molecular imaging in oncology.

  2012cites this paper
• Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.

  2012cites this paper
• PET Radiochemistry and Radiopharmacy

  2012cites this paper
• FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA TRABALHO FINAL DO 6o ANO MÉDICO COM VISTA À ATRIBUIÇÃO DO GRAU DE MESTRE NO ÂMBITO DO CICLO DE ESTUDOS DE MESTRADO INTEGRADO EM MEDICINA

  2012cites this paper
• Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma

  2012cites this paper